Target Price | SEK321.46 |
Price | SEK326.20 |
Deviation |
1.45%
register free of charge
|
Number of Estimates | 11 |
11 Analysts have issued a price target Swedish Orphan Biovitrum 2025 .
The average Swedish Orphan Biovitrum target price is SEK321.46.
This is
1.45%
register free of charge
SEK370.00
13.43%
register free of charge
SEK250.00
23.36%
register free of charge
|
|
A rating was issued by 13 analysts: 7 Analysts recommend Swedish Orphan Biovitrum to buy, 5 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Swedish Orphan Biovitrum stock has an average upside potential 2025 of
1.45%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Billion SEK | 22.12 | 24.88 |
17.74% | 12.46% | |
EBITDA Margin | 35.37% | 36.35% |
2.28% | 2.77% | |
Net Margin | 11.57% | 13.25% |
25.54% | 14.57% |
12 Analysts have issued a sales forecast Swedish Orphan Biovitrum 2024 . The average Swedish Orphan Biovitrum sales estimate is
This results in the following potential growth metrics:
11 Analysts have issued an Swedish Orphan Biovitrum EBITDA forecast 2024. The average Swedish Orphan Biovitrum EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
12 Swedish Orphan Biovitrum Analysts have issued a net profit forecast 2024. The average Swedish Orphan Biovitrum net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share SEK | 7.47 | 9.63 |
12.32% | 28.92% | |
P/E | 33.89 | |
EV/Sales | 5.15 |
12 Analysts have issued a Swedish Orphan Biovitrum forecast for earnings per share. The average Swedish Orphan Biovitrum <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Swedish Orphan Biovitrum stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Swedish Orphan Biovitrum...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.